Also on Trial Friend:Myasthenia Gravis pageCompare treatmentsMatch Me
All 86 Myasthenia Gravis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisMost sites in Florida, California and TexasRecruitingPhase 3Ages 18-80Immunovant Sciences44US sites
24 states - Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)Most sites in California, Florida and North CarolinaRecruitingAges 18+Alexion Pharmaceuticals32US sites
21 states - Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)Most sites in Florida, Texas and North CarolinaRecruitingPhase 3Ages 18+Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany20US sites
12 states - Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia GravisMost sites in Texas, California and MichiganRecruitingPhase 3Ages 18-74Janssen Research & Development19US sites
14 states - A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)Most sites in Florida, California and HawaiiRecruitingPhase 4Ages 18+argenx18US sites
11 states - A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod AlfaMost sites in Florida, Massachusetts and OregonRecruitingAges 18+argenx17US sites
12 states - RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia GravisMost sites in California, Texas and MassachusettsRecruitingPhase 1/2Ages 18-70Cabaletta Bio17US sites
11 states - ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia GravisMost sites in Florida, North Carolina and OhioRecruitingAges 18+argenx15US sites
10 states - ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to EfgartigimodMost sites in Florida, North Carolina and OhioRecruitingPhase 2Ages 18+argenx14US sites
10 states - Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related DiseasesMost sites in California, Florida and MinnesotaRecruitingPhase 1Ages 18+Kite, A Gilead Company14US sites
9 states - A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisMost sites in Florida, Arizona and CaliforniaRecruitingPhase 3Ages 18+Janssen Research & Development11US sites
9 states - Study of Aritinercept in Patients With Generalized Myasthenia GravisMost sites in Florida, Illinois and MichiganRecruitingPhase 1/2Ages 18-85Aurinia Pharmaceuticals11US sites
5 states - KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisMost sites in California, Florida and IndianaRecruitingPhase 2/3Ages 18-75Kyverna Therapeutics10US sites
8 states - The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisMost sites in Tennessee, Colorado and FloridaRecruitingAges 18+Ad scientiam10US sites
9 states - Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia GravisMost sites in Florida, California and ColoradoRecruitingPhase 2Ages 18+NMD Pharma A/S9US sites
8 states - A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia GravisMost sites in Florida, Texas and MissouriRecruitingPhase 1/2Ages 18-74ImmunAbs8US sites
3 states - A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisMost sites in California, Pennsylvania and ArizonaRecruitingPhase 2/3Ages 2-17Janssen Research & Development8US sites
6 states - A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)Most sites in Colorado, Florida and MichiganRecruitingPhase 2Ages 18+TG Therapeutics7US sites
5 states - A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisMost sites in Ohio, Arizona and IllinoisRecruitingPhase 3Ages 18+UCB Biopharma SRL6US sites
5 states - ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia GravisMost sites in California, Florida and NevadaRecruitingPhase 2Ages 18+argenx6US sites
6 states
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Myasthenia Gravis trials in the US, and what stage they are in
Of the 45 Myasthenia Gravis trials with a US site, 11 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 11 of them. Phase 4 studies of an already approved treatment make up 3. The remaining 20 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 32 of them, and universities, hospitals, foundations and government groups run 13. The sponsors with the most are argenx (6), Alexion Pharmaceuticals (4) and Janssen Research & Development (3). The most recently listed one first appeared on ClinicalTrials.gov on August 26, 2026.
Myasthenia Gravis trials in the US, state by state
Of the 45 Myasthenia Gravis trials with a US site, 9 accept children under 18. Their open sites are in 16 states and Washington, DC, most often District of Columbia, Pennsylvania and Arizona. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 28 states
US hospitals running the most Myasthenia Gravis trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Myasthenia Gravis.
- National Neuromuscular Research InstituteAustin, Texas4 trials
- SFM Clinical Research, LLCBoca Raton, Florida4 trials
- University of Kansas Medical CenterKansas City, Kansas4 trials
- University of South FloridaTampa, Florida4 trials
- Visionary Investigators NetworkMiami, Florida4 trials
- Dent Neurologic Institute - AmherstAmherst, New York3 trials
- Erlanger Health SystemChattanooga, Tennessee3 trials
- Henry Ford Health SystemDetroit, Michigan3 trials
- Houston Methodist HospitalHouston, Texas3 trials
- Massachusetts General HospitalBoston, Massachusetts3 trials
Help getting to a Myasthenia Gravis trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Myasthenia Gravis trial near you
Are there Myasthenia Gravis clinical trials near me?
As of November 13, 2026, 86 Myasthenia Gravis clinical trials are recruiting now and 31 are not yet recruiting. In the US, 45 of them have at least 1 open site, across 37 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Myasthenia Gravis clinical trial sites?
Recruiting Myasthenia Gravis trials list open sites in 37 states and Washington, DC. Florida, California and Texas have the most, and the table on this page lists every state.
Are there Myasthenia Gravis trials for children near me?
Of the 45 Myasthenia Gravis trials with a US site, 9 accept children under 18. Their open sites are in 16 states and Washington, DC, most often District of Columbia, Pennsylvania and Arizona. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Myasthenia Gravis clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Myasthenia Gravis trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Myasthenia Gravis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Myasthenia Gravis: Imaavy (nipocalimab), Rystiggo (rozanolixizumab), Soliris (eculizumab), Ultomiris (ravulizumab), Uplizna (inebilizumab), Vyvgart (efgartigimod alfa), Zilbrysq (zilucoplan), Mestinon (pyridostigmine bromide).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.